INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 204 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,540 | +67.6% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $11,060 | -17.6% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $13,430 | +11.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $12,000 | -14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -12.5% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | +6.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $15,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | -13.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $23,000 | -8.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $25,000 | -39.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $41,000 | -14.6% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $48,000 | -23.8% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $63,000 | -49.2% | 1,000 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $124,000 | +87.9% | 1,000 | 0.0% | 0.01% | +66.7% |
| Q3 2019 | $66,000 | -17.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $80,000 | -11.1% | 1,000 | -35.4% | 0.00% | 0.0% |
| Q3 2017 | $90,000 | -54.8% | 1,549 | -11.9% | 0.00% | -57.1% |
| Q1 2017 | $199,000 | -42.8% | 1,759 | -27.8% | 0.01% | -30.0% |
| Q2 2016 | $348,000 | -24.5% | 2,436 | -32.1% | 0.01% | -28.6% |
| Q1 2016 | $461,000 | +4090.9% | 3,587 | +8867.5% | 0.01% | – |
| Q1 2015 | $11,000 | +83.3% | 40 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 2,028,192 | $229,389,000 | 1.76% |
| Orbimed Advisors | 1,037,000 | $117,285,000 | 1.33% |
| BB BIOTECH AG | 255,719 | $28,922,000 | 0.95% |
| ALTRINSIC GLOBAL ADVISORS LLC | 193,369 | $21,870,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 44,573 | $5,041,000 | 0.67% |
| Rhenman & Partners Asset Management AB | 30,000 | $3,393,000 | 0.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 11,155 | $1,262,000 | 0.48% |
| NATIONAL PLANNING CORP | 52,400 | $5,888,000 | 0.44% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 364,232 | $41,195,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 15,000 | $1,697,000 | 0.33% |